Developing Costimulatory Molecules for Immunotherapy of Diseases /

Developing Costimulatory Molecules for Immunotherapy of Diseases /

Saved in:

Bibliographic Details
Main Author:	Mir, Manzoor Ahmad (Author)
Format:	Book
Language:	English
Published:	Amsterdam, Boston : Elsevier, c2015.
Online Access:	View in OPAC
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases
by: Basveshwar Gawali, et al.
Published: (2025-02-01)

Development status of electrocatalytic hydrogenation of biomass small molecules and prospects for industrial production
by: Yuchen Lei, et al.
Published: (2025-02-01)

Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
by: Qiaolin Huang, et al.
Published: (2025-02-01)

Bacterial Vaginosis Bacterial and Epithelial Cell Adhesion Molecules
by: Şayeste Demirezen, et al.
Published: (2013-04-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)

Spin-bearing molecules as optically addressable platforms for quantum technologies
by: Kuppusamy Senthil Kumar, et al.
Published: (2024-10-01)

Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients
by: Amalia Azzariti, et al.
Published: (2025-02-01)

Safe-and-sustainable-by-design redox active molecules for energy storage applications
by: Clemens Wolf, et al.
Published: (2025-02-01)

How energy determines spatial localisation and copy number of molecules in neurons
by: Cornelius Bergmann, et al.
Published: (2025-02-01)

MECHANISMS AND CLINICAL PERSPECTIVES OF ALLERGEN-SPECIFIC IMMUNOTHERAPY
by: Leila Akhvlediani, et al.
Published: (2024-12-01)

Small molecule metabolites drive plant rhizosphere microbial community assembly patterns
by: Yanwei Ma, et al.
Published: (2025-02-01)

An unbiased cell morphology-based screen for new, biologically active small molecules.
by: Masahiro Tanaka, et al.
Published: (2005-05-01)

QeMFi: A Multifidelity Dataset of Quantum Chemical Properties of Diverse Molecules
by: Vivin Vinod, et al.
Published: (2025-02-01)

Discovery of the bacterial HslV protease activators as lead molecules with novel mode of action
by: Aurangzeb Sana, et al.
Published: (2025-02-01)

Organic molecules are deterministically assembled in variably inundated river sediments, but drivers remain unclear
by: James C. Stegen, et al.
Published: (2025-02-01)

Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01)

Increasing the concentration of plasma molecules improves the biological activity of platelet-rich plasma for tissue regeneration
by: Mikel Sánchez, et al.
Published: (2025-02-01)

Efficacy of CLT4A variants as immunoregulatory molecules among Vitiligo patients in Saudi Arabia
by: Amal F. Alshammary, et al.
Published: (2025-02-01)

Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy
by: Weijian Zhu, et al.
Published: (2025-02-01)

Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
by: Razelle Kurzrock, et al.
Published: (2022-09-01)

Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study
by: Syed Mushfiq, et al.
Published: (2025-01-01)

Efficient and Explainable Virtual Screening of Molecules through Fingerprint-Generating Networks Integrated with Artificial Neural Networks
by: Rivaaj Monsia, et al.
Published: (2025-01-01)

Recent advances in small molecule LpxC inhibitors against gram-negative bacteria (2014–2024)
by: Pengpeng Ji, et al.
Published: (2025-02-01)

Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
by: Dingtian Luo, et al.
Published: (2025-02-01)

Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy
by: Minfeng Yang, et al.
Published: (2025-02-01)

Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
by: Xin Liu, et al.
Published: (2022-03-01)

Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review
by: Adekunle Babajide Rowaiye, et al.
Published: (2024-03-01)

Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
by: Xia Liu, et al.
Published: (2022-10-01)

Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
by: Jesse Haramati, et al.
Published: (2025-02-01)

Biology of extracellular vesicles and the potential of tumor-derived vesicles for subverting immunotherapy of cancer
by: Theresa L Whiteside
Published: (2025-01-01)

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
by: Yuankui Zhu, et al.
Published: (2025-02-01)

Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
by: Yunxiang Hu, et al.
Published: (2025-02-01)

AI-enhanced 3D-QSAR screening of fragment-based novel designed molecules targeting Phalaris minor ACCase
by: Bikash Kumar Rajak, et al.
Published: (2025-06-01)

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01)

Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care
by: Drew M Pardoll, et al.
Published: (2025-01-01)

Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy
by: Zhian Chen, et al.
Published: (2025-04-01)

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01)

Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
by: Howard L Kaufman, et al.
Published: (2024-05-01)

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
by: Youmei Xiao, et al.
Published: (2025-02-01)

Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing
by: Alice Perucca, et al.
Published: (2025-02-01)